Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

BACKGROUND: We aimed to investigate the tau biomarker discrepancies of Alzheimer’s disease (AD) using plasma tau phosphorylated at threonine 181 (p-tau181), cerebrospinal fluid (CSF) p-tau181, and AV1451 positron emission tomography (PET). METHODS: In the Alzheimer’s Disease Neuroimaging Initiative,...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Alzheimers Res Ther
Prif Awduron: Guo, Yu, Huang, Yu-Yuan, Shen, Xue-Ning, Chen, Shi-Dong, Hu, Hao, Wang, Zuo-Teng, Tan, Lan, Yu, Jin-Tai
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2021
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094494/
https://ncbi.nlm.nih.gov/pubmed/33947453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-021-00834-3
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg